EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mosaic CDKL5 deficiency drives progressive inhibitory circuit remodelling

Nicola Mottolese iD, Stefania Trazzi, Giorgio Medici iD, Feliciana Iannibelli, Chiara Diquigiovanni, Giulia Candini, Manuela Loi, Federica Trebbi, Angelica Marina Bove, Debora Comai, Marianna Tassinari, Elena Bonora iD und 3 weitere

Brain · 11.11.2026

DOI: 10.1093/brain/awag392 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 11.11.2026. Verfasst von Nicola Mottolese und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical and Neuromotor Sciences, University of Bologna, 40126 Bologna, Italy. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CDKL5 deficiency disorder predominantly affects heterozygous females, in whom random X-chromosome inactivation generates cellular CDKL5 mosaicism. Although mosaicism is a defining feature of the disease, whether it actively drives disease progression or simply reflects the genetic mode of inheritance remains unknown. Here, we combined age-comparative electrophysiology, quantitative synaptic imaging, transcriptomic profiling and postmortem human brain analyses to determine how mosaic CDKL5 deficiency shapes inhibitory circuit remodeling during disease progression. Heterozygous Cdkl5 female mice exhibited striking age- and region-specific remodeling of inhibitory neurotransmission. Hippocampal inhibition was initially enhanced but progressively declined with age, whereas cortical inhibitory transmission remained preserved at 3 months and increased in middle-aged animals. These functional changes were accompanied by dynamic remodeling of inhibitory presynaptic terminals, persistent disruption of inhibitory synapse organization and reduced hippocampal gephyrin-positive puncta despite preservation of the major inhibitory interneuron populations. At 12 months, heterozygous females also exhibited a higher density of IBA1/CD68 double-positive microglia in both regions compared with age-matched wild-type controls. Importantly, complete Cdkl5 deficiency failed to reproduce the progressive loss of inhibitory presynaptic terminals observed in heterozygous females, indicating that this phenotype is specific to the mosaic condition rather than a simple consequence of complete Cdkl5 loss. Transcriptomic profiling revealed a temporal transition from alterations detected at 3 months in immune–synaptic regulatory pathways to activity-dependent transcriptional programs associated with reduced structural and homeostatic support, consistent with progressive hippocampal circuit reorganization. Exploratory analyses of postmortem cortical tissue from individuals with CDD revealed differences in inhibitory presynaptic labeling between the available young and adult cases, suggesting that inhibitory alterations may also vary with age in human CDD. Together, these findings identify mosaic CDKL5 deficiency as a biologically distinct circuit state characterized by progressive, region-specific inhibitory circuit remodeling and provide a mechanistic framework for disease progression in CDKL5 deficiency disorder.

Schlagwörter

Stichwörter der Autor:innen

GABAergic transmissionX-chromosome inactivationcellular CDKL5 mosaicismcortexhippocampusinhibitory synapses

Autor:innen und Institutionen

  • Department of Biomedical and Neuromotor Sciences, University of Bologna, 40126 Bologna, Italy.
  • Department of Medical and Surgical Sciences, University of Bologna, 40126 Bologna, Italy.
  • Rita Levi-Montalcini Department of Neuroscience, University of Turin, 10125 Turin, Italy.
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.
  • Department of Biomedical Sciences, University of Padua, 35121 Padua, Italy.
  • Neuroscience Institute, National Research Council, 56124 Pisa, Italy.

ORCID-Profile: Nicola Mottolese, Giorgio Medici, Elena Bonora, Elisabetta Ciani

Zitieren

APA

Mottolese, N., Trazzi, S., Medici, G., Iannibelli, F., Diquigiovanni, C., Candini, G., Loi, M., Trebbi, F., Bove, A. M., Comai, D., Tassinari, M., Bonora, E., Giustetto, M., Mainardi, M., & Ciani, E. (2026). Mosaic CDKL5 deficiency drives progressive inhibitory circuit remodelling. Brain. https://doi.org/10.1093/brain/awag392

Vancouver

Mottolese N, Trazzi S, Medici G, Iannibelli F, Diquigiovanni C, Candini G, et al. Mosaic CDKL5 deficiency drives progressive inhibitory circuit remodelling. Brain. 2026. doi:10.1093/brain/awag392

BibTeX
@article{Mottolese2026,
  author = {Mottolese, Nicola and Trazzi, Stefania and Medici, Giorgio and Iannibelli, Feliciana and Diquigiovanni, Chiara and Candini, Giulia and Loi, Manuela and Trebbi, Federica and Bove, Angelica Marina and Comai, Debora and Tassinari, Marianna and Bonora, Elena and Giustetto, Maurizio and Mainardi, Marco and Ciani, Elisabetta},
  title = {Mosaic CDKL5 deficiency drives progressive inhibitory circuit remodelling},
  journal = {Brain},
  year = {2026},
  doi = {10.1093/brain/awag392}
}
Kostenlos starten →